Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease essential thrombocythemia
Comorbidity C0040053|thrombosis
Sentences 26
PubMedID- 25269924 Acute myocardial infarction and sub-acute stent thrombosis associated with occult essential thrombocythemia.
PubMedID- 24617727 Decanucleotide insertion polymorphism of f7 significantly influences the risk of thrombosis in patients with essential thrombocythemia.
PubMedID- 24889737 Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history.
PubMedID- 21062242 Hemorrhage, thrombosis and leukemic transformation) of polycythemia vera (pv), essential thrombocythemia (et), and primary myelofibrosis (pmf), the advent of molecular biology has provided substantial molecular insight into the pathobiology of myeloproliferative neoplasia (mpn).
PubMedID- 20074024 Successful pregnancy in a patient with portal hypertension secondary to portal vein thrombosis due to essential thrombocythaemia: a rare case.
PubMedID- 19582452 Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous jak2 v617f mutation.
PubMedID- 21287350 Established risk factors for thrombosis in essential thrombocythemia (et) include age (>/= 60 years) and previous vascular events.
PubMedID- 22781379 [very late coronary drug-eluting stent thrombosis in a patient with essential thrombocythemia: a case report of a rare association].
PubMedID- 25223529 The importance of cardiovascular risk factors for thrombosis prediction in patients with essential thrombocythemia.
PubMedID- 23577924 Cytoreduction plus low-dose aspirin versus cytoreduction alone as primary prophylaxis of thrombosis in patients with high-risk essential thrombocythaemia: an observational study.
PubMedID- 25170413 The risk of thrombosis is high in patients with essential thrombocythemia.
PubMedID- 20483636 The development of bone marrow fibrosis and thrombosis are main causes of morbidity in essential thrombocythemia (et).
PubMedID- 21490340 The current study clarifies the contribution of specific disease and host characteristics to the risk of arterial versus venous thrombosis in essential thrombocythemia.
PubMedID- 24434346 Aim: it is known that thrombocytosis is closely related to vascular complications and particularly thrombosis in essential thrombocytemia (et) cases.
PubMedID- 22768743 [two clinical cases of essential thrombocythemia complicated by thrombosis in parturients].
PubMedID- 25885405 thrombosis in essential thrombocytemia and early/prefibrotic primary myelofibrosis: the role of the who histological diagnosis.
PubMedID- 25997869 The impact of jak2v617f mutation on different types of thrombosis risk in patients with essential thrombocythemia: a meta-analysis.
PubMedID- 22446615 We report a 13-year-old girl who presented with isolated cerebral venous thrombosis and was diagnosed with essential thrombocythemia.
PubMedID- 23033268 Accurate prediction of thrombosis in essential thrombocythemia (et) provides the platform for prospective studies exploring preventive measures.
PubMedID- 25872987 New and treatment-relevant risk stratification for thrombosis in essential thrombocythemia and polycythemia vera.
PubMedID- 22537896 [aortic thrombosis in a patient with essential thrombocythemia].
PubMedID- 24709317 Deep vein thrombosis occurs in 30% of patients with essential thrombocythemia, but rarely at initial diagnosis.
PubMedID- 20085436 Budd-chiari syndrome and portal vein thrombosis due to essential thrombocytosis.
PubMedID- 24084459 The jak2 v617f mutation was strong predictor for thrombosis in essential thrombocytemia patients (relative risk=3.1, 95% ci = 1.7-16.4, p = 0.03).
PubMedID- 20623009 This drug is often used to supplement phlebotomy for patients with polycythemia vera (pv; [2]) and to reduce significantly the incidence of recurrent thrombosis in patients with essential thrombocythemia who are at high risk [3].
PubMedID- 21142409 Cerebral venous thrombosis due to essential thrombocythemia and worsened by heparin-induced thrombocytopenia and thrombosis.

Page: 1